Ocular Therapeutix, Inc.

NASDAQ:OCUL

Biotechnology

Healthcare
$5.86 -1.17%

-$0.11 today

Market cap
$1.29B
Beta
0.90
P/E (TTM)
-7.3
EPS (TTM)
-$1.30
52W Low $6.23High $16.44

Volume 3.08M

Average 3.00M

Price history

Ocular Therapeutix, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-50.00%

Period high

$16.11

Period low

$5.86

Latest

$5.86

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
3Nov 10, 2026Nov 10, 2026
4Nov 10, 2026Nov 10, 2026
8-KNov 9, 2026Nov 9, 2026
4Nov 9, 2026Nov 9, 2026
10-QNov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
S-8Nov 9, 2026Nov 9, 2026
8-KOct 16, 2026Oct 16, 2026
4Oct 13, 2026Oct 13, 2026
4Oct 6, 2026Oct 6, 2026
4Oct 6, 2026Oct 6, 2026
4Sep 2, 2026Sep 2, 2026
4Aug 26, 2026Aug 26, 2026
4Aug 26, 2026Aug 26, 2026
4Aug 26, 2026Aug 26, 2026

Competitors

Who does Ocular Therapeutix, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about OCUL's filings, answered from its disclosures.

What is the latest OCUL filing?

The latest filing shown is 4 dated Nov 10, 2026.

How many recent filings does OCUL have?

Intrinsic Alpha currently shows 20 recent filings for OCUL.